A man has died from meningococcal disease in a hospital in the Hunter region.
This is the first death and third confirmed case in the Hunter New England Health region this year.
The man’s close contacts are being provided with clearance antibiotics.
There are no links between this case and any previous cases.
In 2009 there were 14 cases of meningococcal disease in the Hunter New
England Health region. There were eight cases in 2008 and 12 in 2007.
Public Health Physician Dr David Durrheim said this case is an important reminder of the seriousness of the illness and the potential to develop life threatening complications.
“Tragically people with meningococcal disease can develop serious complications very quickly,” Dr Durrheim said.
“Although most cases of meningococcal disease are seen in infants, young children, teenagers and young adults, people of any age can be infected.”
‘‘The community needs to remain on the alert for the signs and symptoms of meningococcal disease and if anyone suspects meningococcal disease, they should seek medical attention immediately.”
Meningococcal disease is serious and up to 10 per cent of patients Australia-wide can die. The first symptoms of meningococcal disease may include pain in the legs, cold hands and feet and abnormal skin colour.
Later symptoms may include high fever, headache, neck stiffness, dislike of bright lights, nausea and vomiting, a rash of reddish-purple spots or bruises and drowsiness. Babies with the infection can be irritable, not feed properly and have an abnormal cry.
‘‘Meningococcal infection does not spread easily. It is spread by secretions from the nose and throat of a person who is carrying it and close and prolonged contact is needed to pass it on. It does not appear to be spread through saliva or by sharing drinks, food or cigarettes,’’ Dr Durrheim said.
He said that while meningococcal disease could be serious, in most cases, early detection and treatment resulted in a complete recovery.
The two main strains of meningococcal disease in Australia are the B and C strains.
A vaccine is effective against the less common meningococcal C strain, but there is currently no Australian vaccine for the B strain of the disease.